(Q38003344)

26 August 2017

title

Comprehensive review of factors implicated in the heterogeneity of response in depression (English)

1 reference

26 August 2017

1 reference

Gebra Cuyún Carter

1

1 reference

26 August 2017

Ronald A Cantrell

2

1 reference

26 August 2017

Victoria Zarotsky

3

1 reference

26 August 2017

Virginia S Haynes

4

1 reference

26 August 2017

Glenn Phillips

5

1 reference

26 August 2017

Carlos I Alatorre

6

1 reference

26 August 2017

Iris Goetz

7

1 reference

26 August 2017

Rosirene Paczkowski

8

1 reference

26 August 2017

Lauren B Marangell

9

1 reference

26 August 2017

language of work or name

1 reference

1 April 2012

1 reference

26 August 2017

published in

Depression and Anxiety

1 reference

26 August 2017

volume

29

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

340-354

1 reference

Dealing with heterogeneity of treatment effects: is the literature up to the challenge?

26 August 2017

cites work

1 reference

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

21 January 2018

1 reference

Diagnosis and definition of treatment-resistant depression

21 January 2018

1 reference

Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment

21 January 2018

1 reference

Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages

21 January 2018

1 reference

A review of treatment response in type 2 diabetes: assessing the role of patient heterogeneity

21 January 2018

1 reference

Review of treatment response in rheumatoid arthritis: assessment of heterogeneity

21 January 2018

1 reference

Gender differences in treatment response to sertraline versus imipramine in chronic depression

21 January 2018

1 reference

A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender

21 January 2018

1 reference

Response, partial response, and nonresponse in primary care treatment of depression

21 January 2018

1 reference

Comparison of response to fluvoxamine in nondemented elderly compared to younger patients affected by major depression

21 January 2018

1 reference

Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial

21 January 2018

1 reference

Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder

21 January 2018

1 reference

Clinical features and treatment response of patients with major depression and silent cerebral infarction

21 January 2018

1 reference

Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day.

21 January 2018

1 reference

Late-onset major depression: clinical and treatment-response variability

21 January 2018

1 reference

Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline

21 January 2018

1 reference

Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders

21 January 2018

1 reference

Adverse life events and cognitive-personality characteristics in the prediction of major depression and antidepressant response

21 January 2018

1 reference

Longitudinal investigation of depression outcomes in primary care in six countries: the LIDO study. Functional status, health service use and treatment of people with depressive symptoms

21 January 2018

1 reference

Are there gender differences in major depression and its response to antidepressants?

21 January 2018

1 reference

The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.

21 January 2018

1 reference

Predicting response to depression treatment: the role of negative cognition.

21 January 2018

1 reference

Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression

21 January 2018

1 reference

Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.

21 January 2018

1 reference

Trajectories of treatment response in late-life depression: psychosocial and clinical correlates

21 January 2018

1 reference

High vitamin B12 level and good treatment outcome may be associated in major depressive disorder

21 January 2018

1 reference

Predictors of treatment response for depression and inadequate social support--the ENRICHD randomized clinical trial

21 January 2018

1 reference

Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression

21 January 2018

1 reference

Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression

21 January 2018

1 reference

Stage of chronicity and treatment response in patients with musculoskeletal injuries and concurrent symptoms of depression.

21 January 2018

1 reference

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

21 January 2018

1 reference

Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study

21 January 2018

1 reference

Low-income depressed older adults with psychiatric comorbidity: secondary analyses of response to psychotherapy and case management.

21 January 2018

1 reference

Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline

21 January 2018

1 reference

Impact of pain on depression treatment response in primary care

21 January 2018

1 reference

Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder

21 January 2018

1 reference

Overweight and obesity affect treatment response in major depression

21 January 2018

1 reference

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment

21 January 2018

1 reference

The effects of antidepressant medication adherence as well as psychosocial and clinical factors on depression outcome among older adults.

21 January 2018

1 reference

NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients

21 January 2018

1 reference

Dimensional personality traits and treatment outcome in patients with major depressive disorder

21 January 2018

1 reference

Low red cell folate levels are associated with poor response to nortriptyline in major depression

21 January 2018

1 reference

Quality of life in geriatric depression: a comparison of remitters, partial responders, and nonresponders

21 January 2018

1 reference

Functioning and interpersonal relationships as predictors of response in treatment-resistant depression.

21 January 2018

1 reference

Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes

21 January 2018

1 reference

Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial

21 January 2018

1 reference

The impact of nonclinical factors on care use for patients with depression: a STAR*D report

21 January 2018

1 reference

Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.

21 January 2018

1 reference

Ethnicity/race and outcome in the treatment of depression: results from STAR*D.

21 January 2018

1 reference

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

Income and attrition in the treatment of depression: a STAR*D report.

21 January 2018

1 reference

Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis

21 January 2018

1 reference

Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials

21 January 2018

1 reference

Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report.

21 January 2018

1 reference

7 January 2021

Perceived parenting pattern and response to antidepressants in patients with major depression

1 reference

7 January 2021

Which depressed patients respond to nefazodone and when?

1 reference

7 January 2021

Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo

1 reference

7 January 2021

Time to response for duloxetine 60 mg once daily versus placebo in elderly patients with major depressive disorder

1 reference

7 January 2021

Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response

1 reference

7 January 2021

1 reference

7 January 2021

Predictors of Treatment Response and Length of Stay for Inpatients with Major Depression

1 reference

7 January 2021

Patient beliefs predict response to paroxetine among primary care patients with dysthymia and minor depression

1 reference

7 January 2021

Dropouts versus completers among chronically depressed outpatients

1 reference

7 January 2021

Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.

1 reference

7 January 2021

Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study

1 reference

7 January 2021

Impact of pain on the outcomes of depression treatment: results from the RESPECT trial

1 reference

7 January 2021

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1

1 reference

7 January 2021

Characteristics, treatment patterns, and outcomes of persistent depression despite treatment in primary care

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.21918

1 reference

26 August 2017

1 reference